IMMUNIC, INC. - Common Stock, $0.0001 par value (IMUX)

CUSIP: 4525EP101

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Common Stock, $0.0001 par value
Shares outstanding
131,806,674
Total 13F shares
42,691,219
Share change
-7,487,323
Total reported value
$37,637,800
Put/Call ratio
38%
Price per share
$0.88
Number of holders
61
Value change
-$6,010,022
Number of buys
24
Number of sells
19

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 4525EP101?
CUSIP 4525EP101 identifies IMUX - IMMUNIC, INC. - Common Stock, $0.0001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of IMUX - IMMUNIC, INC. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Adage Capital Management, L.P.
13D/G
10%
10,479,337
$8,697,850 +$7,537,012 30 Jun 2025
Aberdeen Group plc
13F
Company
6.3%
8,243,941
$5,750,149 30 Jun 2025
13F
BVF INC/IL
13F
Company
5.8%
7,652,972
$5,337,948 30 Jun 2025
13F
Soleus Capital Management, L.P.
13F
Company
5.5%
7,293,007
$5,086,872 30 Jun 2025
13F
VANGUARD GROUP INC
13D/G 13F
The Vanguard Group · Company
4.4%
3,923,763
$4,473,090 $0 31 Dec 2024
Avidity Partners Management LP
13D/G 13F
Company
4.8%
4,699,411
$4,143,001 -$807,898 30 Sep 2025
MORGAN STANLEY
13F
Company
2.8%
3,628,528
$2,530,899 30 Jun 2025
13F
Focus Partners Wealth
13F
Company
1.9%
2,542,524
$1,773,413 30 Jun 2025
13F
Soleus Private Equity Fund III, L.P.
13D/G
Soleus Capital Management, L.P.
1.6%
1,580,007
$1,392,934 $0 30 Sep 2025
Laurion Capital Management LP
13F
Company
1.4%
1,905,063
$1,328,781 30 Jun 2025
13F
Omega Fund Management, LLC
13F
Company
1.4%
1,788,160
$1,248,136 30 Jun 2025
13F
RTW INVESTMENTS, LP
13D/G 13F
Company
1.1%
1,026,762
$1,170,509 $0 31 Mar 2025
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
1.1%
1,398,600
$975,524 30 Jun 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.74%
974,636
$680,012 30 Jun 2025
13F
Ikarian Capital, LLC
13F
Company
0.69%
914,170
$637,633 30 Jun 2025
13F
Ghisallo Capital Management LLC
13F
Company
0.63%
835,000
$582,413 30 Jun 2025
13F
BlackRock, Inc.
13F
Company
0.53%
698,739
$487,371 30 Jun 2025
13F
Daniel Vitt
3/4/5
CEO and Director, Director
mixed-class rows
2,809,877
mixed-class rows
$352,548 +$11,550 16 Jul 2025
UBS Group AG
13F
Company
0.29%
376,104
$262,521 30 Jun 2025
13F
STATE STREET CORP
13F
Company
0.25%
331,945
$231,532 30 Jun 2025
13F
NORTHERN TRUST CORP
13F
Company
0.2%
258,319
$180,177 30 Jun 2025
13F
BOOTHBAY FUND MANAGEMENT, LLC
13F
Company
0.18%
240,873
$168,009 30 Jun 2025
13F
Richard A. Rudick
3/4/5
Director
mixed-class rows
480,375
mixed-class rows
$161,055 +$100,024 05 Jun 2025
Joerg Neermann
3/4/5
Director
mixed-class rows
450,000
mixed-class rows
$152,000 +$76,700 05 Jun 2025
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.1%
132,154
$92,177 30 Jun 2025
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.09%
115,000
$80,213 30 Jun 2025
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.08%
103,109
$71,919 30 Jun 2025
13F
Strategies Wealth Advisors, LLC
13F
Company
0.08%
100,000
$69,750 30 Jun 2025
13F
Glenn Whaley
3/4/5
Chief Financial Officer
mixed-class rows
879,010
mixed-class rows
$68,079 +$32,076 16 Jul 2025
GROUP ONE TRADING LLC
13F
Company
0.06%
75,899
$52,940 30 Jun 2025
13F
683 Capital Management, LLC
13F
Company
0.05%
62,458
$43,564 30 Jun 2025
13F
MARSHALL WACE, LLP
13F
Company
0.04%
49,991
$34,994 30 Jun 2025
13F
Duane Nash
3/4/5
Executive Chairman, Director
mixed-class rows
921,032
mixed-class rows
$30,075 +$16,694 16 Jul 2025
Creative Planning
13F
Company
0.03%
35,000
$24,413 30 Jun 2025
13F
Bank of New York Mellon Corp
13F
Company
0.02%
30,456
$21,243 30 Jun 2025
13F
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)
13F
Company
0.02%
30,000
$20,940 30 Jun 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.02%
25,000
$17,438 30 Jun 2025
13F
Ring Mountain Capital, LLC
13F
Company
0.01%
18,039
$17,390 30 Jun 2025
13F
Marex Group plc
13F
Company
0.02%
22,500
$15,694 30 Jun 2025
13F
ROYAL BANK OF CANADA
13F
Company
0.02%
21,700
$15,000 30 Jun 2025
13F
Jason Tardio
3/4/5
President and COO
mixed-class rows
941,012
mixed-class rows
$9,884 +$9,884 16 Jul 2025
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.01%
13,151
$9,173 30 Jun 2025
13F
Balboa Wealth Partners
13F
Company
0.01%
12,000
$8,370 30 Jun 2025
13F
LEVEL FOUR ADVISORY SERVICES, LLC
13F
Company
0.01%
10,780
$7,519 30 Jun 2025
13F
PFG Investments, LLC
13F
Company
0.01%
10,500
$7,324 30 Jun 2025
13F
Retirement Planning Group, LLC
13F
Company
0.01%
10,417
$7,266 30 Jun 2025
13F
Private Advisor Group, LLC
13F
Company
0.01%
10,000
$6,976 30 Jun 2025
13F
Crescent Grove Advisors, LLC
13F
Company
0.01%
10,000
$6,975 30 Jun 2025
13F
Dynamic Advisor Solutions LLC
13F
Company
0.01%
10,000
$6,975 30 Jun 2025
13F
JPMORGAN CHASE & CO
13F
Company
0.01%
8,709
$6,075 30 Jun 2025
13F

Institutional Holders of IMMUNIC, INC. - Common Stock, $0.0001 par value (IMUX) as of Q3 2025

As of 30 Sep 2025, IMMUNIC, INC. - Common Stock, $0.0001 par value (IMUX) was held by 61 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 42,691,219 shares. The largest 10 holders included Aberdeen Group plc, BVF INC/IL, Avidity Partners Management LP, VANGUARD GROUP INC, MORGAN STANLEY, Focus Partners Wealth, Laurion Capital Management LP, Soleus Capital Management, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C., and GEODE CAPITAL MANAGEMENT, LLC. This page lists 61 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
55
Q3 2025 holders
61
Holder diff
6
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 Value $ Q3 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.